newsfilter
← Latest News
GlobeNewswire·

Progenity to Participate in Crohn's & Colitis Foundation's Fourth Annual IBD Innovate Conference

SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohn's & Colitis virtual confe